NEWSROOM

Pet Pain Away

Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon

Nutra Pharma is announcing their newest product, Luxury Feet; is now available for purchase on Amazon.com   Plantation, Florida, April 15, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that their newest product, Luxury...

read more

Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels

Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos   Plantation, Florida, March 16, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human...

read more

Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials

  Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical trials   Plantation, Florida,  March 11, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple...

read more

Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications

  Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation   Plantation, Florida, February 23, 2021  -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain,...

read more

Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys

  Plantation, Florida, February 12, 2021 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that they are focusing on their intellectual property portfolio and have engaged their IP attorneys at Christopher & Weisberg P.A....

read more

Nutra Pharma Letter to Shareholders

  Plantation, Florida, January 12, 2021 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, has published a Letter to Shareholders on the Company's website. “The last year was...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »